"We saw indications that some practices that we know too well may lead to tipping and to the emergence of gatekeepers," European Competition Commissioner Margrethe Vestager told reporters.
"If large private companies are not held to the same level of scrutiny as public companies, we will create an unintended incentive to shift carbon-intensive assets to markets with less transparency and, often, less regulation," Fink wrote.
Fink's language was more specific than in a January memo in which he said climate disclosures "should be embraced" by large private companies.
"If Austria receives an additional one million vaccine doses, we will be able to return to normality faster and could save many lives as well as jobs," Kurz said.
The expected deal would see Air France give up fewer airport flight slots at its Paris base than initially sought by the European Commission, notably at Orly airport, the newspaper said in a report published late on Friday.
The Air France-KLM group recorded a 7.1 billion euro ($8.38 billion) net loss for last year.
The COVID-19 pandemic and vaccine supply bottlenecks have spurred regulatory interest in the pharmaceutical industry which has seen a wave of consolidation in recent years.
The EU competition enforcer said greater scrutiny of pharmaceutical deals was needed to single out those that might lead to higher drug prices, lower innovation or anti-competitive conduct.
Bankers have said that the travel restrictions due to the pandemic have made it harder to shift staff to new locations, but EU regulators are running out of patience.
"One key issue for our attention is that we have sufficient strategic and risk-management capacity onshore here. We are not there yet, for some banks we are but not for all the banks," Enria said.